In this issue:
Consolidation prednisolone ±thalidomide after autologous
SCT in newly diagnosed MM
GEP alone does not predict CR in MM
Physical functioning after autologous SCT in MM
Preventing severe infections with levofloxacin in bortezomibtreated MM
Carfilzomib/thalidomide/ dexamethasone for newly diagnosed MM
Ixazomib/lenalidomide/dexamethasone in previously untreated MM
Carfilzomib/lenalidomide/ dexamethasone for relapsed MM
Exosomal miR-135b from hypoxic MM cells enhances angiogenesis
Pim-2 kinase: a target of treating tumour progression and bone loss in MM
Please login below to download this issue (PDF)